跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Famoxa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Famoxa
Approved
STANDARD
Famoxa
Hebei Tiancheng Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4cdae69a93716f1c
Company
Hebei Tiancheng Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
4cdae69a93716f1c
Drug Approval Philippines Name
Famoxa
Product Name
Famoxa
Registration Number
DRP-11321
Brand Name
Famoxa
Generic Name
Ofloxacin
Dosage Form
Solution For Intravenous Infusion
Dosage Strength
200mg/100mL
Manufacturer
Hebei Tiancheng Pharmaceutical Co., Ltd.
Importer
AMB HK Enterprises Inc.
Issuance Date
28 February 2022
Expiry Date
28 February 2027
Pharmacologic Category
Antibacterial (Quinolone)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4cdae69a93716f1c
Type
Standard
Back to Philippines FDA Approvals